SEC Form 4 · accession 0001209191-15-072159
Dare Bioscience, Inc. · DARE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David R Walt
Director
Period of report
Feb 23, 2015
Accepted (ET)
Sep 25, 2015 · 1:31 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001401914
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $4.80 | Sep 23, 2015 | A | 22,000 | A | — | Sep 22, 2025 | Common Stock | 22,000 | 22,000 | D |
Explanation of responses
- F1This option was granted on September 23, 2015. The shares underlying this option vest in three equal installments on September 23, 2016, September 23, 2017 and September 23, 2018, respectively, subject to Mr. Walt's continued service as a director of the Corporation.